While developing a vaccine for COVID-19, a Top 3 pharmaceutical company had an urgent need. After the primary endpoints in their trial had been met, they needed to minimize data management hours spent reconciling discrepancies in their EDC system, with the goal of reaching the market — and patients — as fast as possible.